Hyperphosphatemia: A Serious Limiting Factor Preventing the Possible Benefit from Intravenous Calcitriol Therapy

Publisher： Karger

E-ISSN： 2235-3186|82|1|77-78

ISSN： 1660-8151

Source： Nephron, Vol.82, Iss.1, 1999-04, pp. : 77-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Effect of Intravenous Calcitriol Administration on Secondary Hyperparathyroidism

By  

Nephron, Vol. 90, Iss. 4, 2002-04 ,pp. : 413-423

Karger

Access to resources Recommend Favorite

Hyperphosphatemia Modestly Retards Parathyroid Hormone Suppression during Calcitriol-Induced Hypercalcemia in Normal and Azotemic Rats

By  

Nephron, Vol. 92, Iss. 4, 2002-10 ,pp. : 883-888

Karger

Access to resources Recommend Favorite

Effect of Intravenous Calcitriol on Cardiac Systolic and Diastolic Function in Patients on Hemodialysis

By  

American Journal of Nephrology, Vol. 18, Iss. 5, 1998-09 ,pp. : 404-410

Karger

Access to resources Recommend Favorite

Intravenous Calcitriol Improves Anaemia and Reduces the Need for Erythropoietin in Haemodialysis Patients

By  

Nephron, Vol. 78, Iss. 1, 1997-12 ,pp. : 23-27

Karger

Access to resources Recommend Favorite

Effectiveness of Intravenous and Subcutaneous Calcitriol inthe Treatment of Secondary Hyperparathyroidism

By  

Nephron, Vol. 80, Iss. 1, 1998-09 ,pp. : 119-120

Karger

Access to resources Recommend Favorite